Articles Archives - Page 166 of 757

TuesdayNov 14, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyes $200 Billion GLP-1 Market with its DehydraTECH(TM) Technology

Lexaria, a global innovator in drug delivery platforms, is exploring the impact of its patented DehydraTECH(TM) technology on the oral performance of GLP-1 drugs for potential diabetes and weight loss treatment The company hopes to make these drugs more effective with reduced side effects, and even more accessible to people living with diabetes The move is aimed to help the company partner with the behemoths in an industry projected to bring in between $150 billion and $200 billion a year Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, is evaluating the impact of its patented DehydraTECH(TM) technology…

MondayNov 13, 2023 10:30 am

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) on Mission to Bring Rare Earth Separation Facilities to North America

The rare earth metals market was valued at $5.3 billion in 2021 and is projected to grow at a CAGR of 12.3%, resulting in a value of $9.6 billion by 2026 The growing tensions between China and the United States make it more important than ever for sustainable REE (Rare Earth Element) separation operations that do not depend on China, and Ucore's RapidSX(TM) technology is key to the answer Ucore plans is developing its first Strategic Metals Complex for REE separation in Louisiana The demand for rare earth elements (“REE”) is expected to surge as the electric vehicle and renewable…

MondayNov 13, 2023 9:45 am

Diamond Lake Minerals Inc. (DLMI) Bridges Gap Between Old-school Business Models, New-school Digital Assets

Utah-based Diamond Lake Minerals Inc. is a vertically integrated company focused on digital assets and securities, focused on building and acquiring enterprises in sectors ranging from music and entertainment to real estate, healthcare, and digital tokens The company has welcomed a new CEO and several new strategic advisors since late August, building market value to $84 million in market cap One of DLMI’s aims is to be a “hybrid missing piece”, getting generational wealth to overcome modernization acquisition hurdles and become involved in the digital assets space Multi-strategy operating company Diamond Lake Minerals (OTC: DLMI) is building a digital vision…

MondayNov 13, 2023 9:00 am

SenesTech Inc. (NASDAQ: SNES) Begins Taking Orders for their new Soft Bait Rodent Contraceptive That Provides Unique Approach to Pest Control

Arizona-based SenesTech Inc. provides a unique approach to rodent pest control by formulating a contraceptive that works as birth control in both male and female rats A major milestone has been reached by the company as it recently began taking orders for its new Evolve(TM) Soft Bait formulation, which joins SenesTech’s liquid ContraPest(R) brand as a population-control solution that avoids some of the problems associated with lethal rodenticides The Evolve(TM) Soft Bait product is targeting the vast professional pest control market that prefers a non-liquid product, as well as providing a consumer-friendly option that may be marketed through big box…

FridayNov 10, 2023 9:45 am

Clene Inc. (NASDAQ: CLNN) Among Grant Awardees Selected to Advance Scientific Research on ALS

Clene, a company targeting the treatment of neurodegenerative diseases that severely impact people’s lives, is currently focusing on amyotrophic lateral sclerosis (“ALS”) alongside other neurodegenerative diseases The company’s wholly owned subsidiary, Clene Nanomedicine, and two collaborators, Columbia University and Synapticure, are the recipients of a four-year grant totaling $45.1 million The grant will support an Expanded Access Protocol (“EAP”) study for Clene’s investigational product, CNM-Au8(R) CNM-Au8 is an orally administered gold nanocrystal suspension that is thought to improve mitochondrial health and protect neuronal function to treat neurodegenerative diseases, including ALS The EAP study will give patients who did not initially…

FridayNov 10, 2023 9:00 am

Renovaro Biosciences Inc. (NASDAQ: RENB) CEO Provides Update on Combination with AI Expert GEDiCube Intl Ltd. in Letter to Shareholders

The agreement with GEDiCube rebrands the company as a wholly-owned subsidiary under the name Renovaro.AI The combined company brings together two innovative platforms in AI and biotherapeutics to offer comprehensive solutions spanning early detection, diagnostic insights, and targeted immunotherapies, for cancer and other diseases The AI division intends to launch commercial products for early cancer detection and improved therapy selection in 2024 – rapidly expanding the largely untapped precision medicine market In September, Renovaro Biosciences (NASDAQ: RENB), an advanced, preclinical biotechnology company focused on cell, gene, and immunotherapy, and GEDiCube Intl Ltd., an AI medical technology company, announced a definitive…

ThursdayNov 09, 2023 10:30 am

Freight Technologies Inc. (NASDAQ: FRGT) Secures Request for Quotation with Global Pharmaceutical Conglomerate for Secure Product Transport

Freight Technologies announced securing a Request for Quotation from a leading global pharmaceutical giant that awards the company 33 lanes of transport pharmaceutical goods from the United States to Canada and Mexico The Request for Quotation extends over seven months, and Fr8App will provide uninterrupted, end-to-end logistics solutions, including secure transport, tracking, and reporting for each load The company’s dedicated team of professionals will oversee this vital operation to guarantee the smooth and efficient delivery of the pharmaceutical company’s critical products Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a technology company developing solutions to optimize and automate the supply chain process through…

ThursdayNov 09, 2023 9:00 am

QuantMinds International 2023 Comes To London

Leading industry academics, practitioners, and engineers, will gather at the QuantMinds International 2023 conference in London from November 13-16, 2023. They will discuss and share in-depth insights into the latest trends and cutting-edge technologies in quant finance for better scope in their future endeavours. Over 500 industry practitioners and academics, 110+ asset managers, and 8 out of the 10 top banks of Europe are expected to grace the event. On the opening day of the summit on November 13, 2023, numerous workshops and interactive sessions will be held as follows: LLMs & Advanced ML Summit: Learn about the innovative applications,…

WednesdayNov 08, 2023 9:45 am

Diamond Lake Minerals Inc. (DLMI) Represents an Attractive Option For Those Looking To Enter The World of Digital Assets

The digital assets market is expected to reach US$56.42 billion by the end of 2023 Diamond Lake Minerals’ mission is to facilitate SEC-registered tokens that allow people to easily invest, through stock, in an industry that can otherwise be confusing to newcomers The company offers investors cutting-edge technology, an experienced team, market potential, regulatory compliance, and a diverse portfolio Digital assets are any valuable digital or virtual item, including cryptocurrency, digital tokens, non-fungible tokens (“NFTs”), and more, created, stored, and traded on a digital platform like blockchain. These digital assets are bought, sold, and traded like traditional assets. By the…

WednesdayNov 08, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Exploring Patented DehydraTECH(TM) Technology’s Effectiveness on GLP-1 Drugs for Potential Diabetes Treatment and Weight Loss

Lexaria, a global innovator in drug delivery platforms, recently announced plans to launch new human and animal studies examining whether its patented DehydraTECH(TM) technology can make GLP-1 drugs better Lexaria has previously demonstrated DehydraTECH’s overall potential in its DIAB-A22-1 animal study, which yielded weight loss, and improved triglyceride and cholesterol levels among diabetic-conditioned animals The company plans to replicate the results from this study while also exploring ways to improve the overall bioavailability of GLP-1 drugs for diabetes treatment and weight loss Lexaria management is optimistic that it will build on previous studies, replicate previous positive results, and improve the…

Site Search

Company Search

Category: Articles